A New Highly Thyrotropin Receptor-Selective Small-Molecule Antagonist with Potential for the Treatment of Graves' Orbitopathy-Reference-Cited by-同舟云学术

A New Highly Thyrotropin Receptor-Selective Small-Molecule Antagonist with Potential for the Treatment of Graves' Orbitopathy

Published:2019-01 Issue:1 Volume:29 Page:111-123
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Marcinkowski Patrick¹,Hoyer Inna¹,Specker Edgar¹,Furkert Jens¹,Rutz Claudia¹,Neuenschwander Martin¹,Sobottka Sebastian¹,Sun Han¹,Nazare Marc¹,Berchner-Pfannschmidt Utta²,von Kries Jens Peter¹,Eckstein Anja²,Schülein Ralf¹,Krause Gerd¹

Affiliation:

1. Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany.

2. Department of Ophthalmology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2018.0349

Reference71 articles.

1. A molecular dissection of the glycoprotein hormone receptors

2. The Thyrotropin (TSH)-Releasing Hormone Receptor: Interaction with TSH and Autoantibodies

3. Thyrotropin receptor-associated diseases: from adenomata to Graves disease

4. Comparison of Efficacy and Adverse Effects Between Methimazole 15 mg+Inorganic Iodine 38 mg/Day and Methimazole 30 mg/Day as Initial Therapy for Graves' Disease Patients with Moderate to Severe Hyperthyroidism

5. Expression of functional TSH receptor in white adipose tissues of hyt/hyt mice induces lipolysis in vivo

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Thyroid-Stimulating Hormone Receptor: A Perspective on Small-Molecule Modulators and Their Therapeutic Potential;Journal of Medicinal Chemistry;2024-09-13

2. Graves disease: latest understanding of pathogenesis and treatment options;Nature Reviews Endocrinology;2024-07-22

3. Recent Advances of Second‐Line Targeted Biopharmaceutical Therapies in Thyroid Associated Ophthalmopathy;Advanced Therapeutics;2024-07-05

4. Low molecular inverse agonist of the thyrotropin receptor is active both intraperitoneal and oral administration;Российский физиологический журнал им И М Сеченова;2024-06-28

5. Prospects for targeted therapy of Graves' disease: A review;Consilium Medicum;2024-05-20